
A nasal spray studied for focus
Prescription required. Dispensed only by a licensed 503A pharmacy after a provider visit. Compounded medications are not FDA-approved.
Virtual consult required
This peptide requires a brief virtual visit before our team can prescribe.
Virtual Consult
Our licensed provider reviews your health profile via secure video — typically 10 minutes. Required for any peptide prescription.
Refund Policy: If found not eligible due to health reasons after consultation, you will receive a full refund.
Semax is modeled on ACTH fragment 4-10, without the hormonal activity of ACTH itself. In animal studies it raises brain-derived neurotrophic factor (BDNF) and affects dopamine and serotonin signaling.
Semax was developed in Russia in the 1980s and is used there by prescription. It is not FDA-approved for any use in the United States, and most published research comes from Russian and animal studies. In October 2026, HHS issued an interim enforcement policy covering Semax when a licensed pharmacy compounds it as a single-ingredient nasal spray for an individual prescription, under set conditions. That policy is not an FDA approval.
Patients usually ask about Semax for focus during demanding stretches of work or study. It is not a treatment for ADHD or any other condition. Your provider reviews your history and medications and decides with you whether it fits.